CALM earnings analysis
What we found in CALM's 10-K: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Cal-Maine’s FY2026 results normalized sharply from the exceptional HPAI-driven price environment of FY2025: revenue fell 31.7% to $2.912 billion, operating income fell 77.2% to $350.2 million, and diluted EPS fell to $6.63 from $24.95. The strategic offset is accelerated diversification into prepared foods through Echo Lake, Creighton and Van’s, with Prepared Foods reaching $244.8 million of sales and $33.9 million of segment income. The company retains substantial liquidity and no revolver debt, but conventional egg-price volatility, new antitrust proceedings and ongoing HPAI exposure leave the near-term outlook balanced rather than clearly positive.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Scale and vertically integrated platform
- Cal-Maine describes itself as the largest U.S. egg company, selling approximately 1.2 billion dozen shell eggs in fiscal 2026 and operating a flock of approximately 50.0 million layers plus 14.5 million pullets and breeders at May 30, 2026. Its strategy is to expand specialty eggs and prepared foods, pursue disciplined acquisitions, and leverage scale, vertical integration and financial strength.
- Prepared Foods diversifies earnings
- Prepared Foods became a meaningful diversification leg following acquisitions: sales rose to $244.8 million, or 8.4% of fiscal-2026 net sales, from $4.1 million in fiscal 2025; segment income improved to $33.9 million from a $2.1 million loss. Echo Lake Foods was the principal driver, acquired for $275.4 million in cash.
- Earnings normalize after FY2025 peak
- The three-year record shows a sharp price-cycle inflection: revenue rose from $2.326 billion in FY2024 to $4.262 billion in FY2025, then fell 31.7% to $2.912 billion in FY2026. Diluted EPS moved from $5.69 to $24.95 and then $6.63, as conventional egg prices normalized after HPAI-driven supply disruption.
- Cash generation and liquidity remain strong
- Despite the downcycle, FY2026 generated $479.8 million of operating cash flow and approximately $328.5 million of free cash flow after $151.2 million of PP&E purchases. The balance sheet had $107.2 million of cash, $816.8 million of available-for-sale securities and no revolver borrowings at year-end.
- Active M&A, capex and buyback deployment
- Capital allocation emphasized both M&A and shareholder returns: Cal-Maine spent $427.8 million on business acquisitions, $151.2 million on PP&E, $131.1 million on share repurchases, and $231.6 million on dividends. The $500 million buyback program had $320.7 million remaining authorization at May 30, 2026.
- Specialty mix offers relative price stability
- Specialty eggs provide comparatively steadier pricing exposure: specialty volume rose 2.4% while average price fell 9.5%, versus a 50.9% price decline in conventional eggs. Most specialty pricing is cost-of-production based, whereas almost all conventional volume is market-based or hybrid priced.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- New antitrust litigation and investigations
- New antitrust exposure intensified: lawsuits filed since November 2025 alleging nationwide conventional-egg price inflation were consolidated into multidistrict litigation in February 2026. Cal-Maine also received DOJ, New York and Washington inquiries; it agreed with the DOJ and 17 states to pay $1.5 million and donate 1 million eggs, while Washington did not join and potential losses cannot yet be estimated.
- Oversupply creates egg-price downside
- Conventional pricing remains the largest earnings sensitivity. Conventional Shell Eggs sales fell 51.1% to $1.348 billion and segment income fell 83.2% to $216.6 million as average conventional price per dozen declined 50.9%; volume was relatively flat. USDA estimated 312.0 million U.S. layer hens at July 1, 2026, above the 308.0 million five-year average, indicating ample supply.
- Recurring HPAI exposure
- HPAI remains a material supply and operating disruption risk even as the flock recovered: 40.2 million and 45.2 million commercial layer hens and pullets were depopulated in 2024 and 2025, respectively, and 19.2 million were depopulated through July 20, 2026. Disease-driven mortality can require abnormal flock-inventory write-downs and disrupt production.
- Variable dividend remains suspended
- The variable dividend is suspended following the Q4 loss. No fourth-quarter FY2026 dividend will be paid, and subsequent dividends require cumulative profitability from the last dividend-paying quarter; the cumulative loss to recover was $35.9 million at fiscal year-end.
- M&A integration and valuation risk
- Acquisition and integration exposure increased materially: goodwill rose to $97.1 million from $46.8 million, while Echo Lake represented 9.7% of total assets and 7.8% of FY2026 sales. Management excluded Echo Lake from its year-end internal-control assessment while it integrates the business into its control framework.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $6.63
- Gross margin
- 23.1%
- Operating margin
- 12.0%
- Segment
- Conventional Shell Eggs: $1.348 billion segment sales, down 51.1% YoY; segment income $216.6 million, down 83.2%.
- Segment
- Specialty Shell Eggs: $1.070 billion segment sales, down 7.3% YoY; segment income $181.5 million, down 45.6%.
- Segment
- Prepared Foods: $244.8 million segment sales, up $240.8 million YoY; segment income $33.9 million versus a $2.1 million loss.
- Segment
- Other/non-reportable operations: $308.0 million external sales, down from $427.7 million.
What they said about what is next.
The 10-K provides no formal numeric revenue or EPS outlook. Management says wholesale egg prices are volatile and that fiscal first and fourth quarters historically can have lower prices, volumes and sales; it also expects current liquidity, operating cash flow and the $250 million revolver to fund needs for at least the next 12 months.
The filing reads about the same as the one before it.
What came before.
- 10-Q · April 1, 2026
- Cal‑Maine reported net sales of $666,951 and diluted EPS of $1.06 for the thirteen weeks ended February 28, 2026, with sharply compressed margins versus the year‑ago quarter following lower egg prices and acquisitions.…
- 10-Q · October 1, 2025
- Cal‑Maine reported net sales of $922,602 (in thousands) and diluted EPS of $4.12 for the thirteen weeks ended August 30, 2025, up versus the year-ago quarter but below the most recent quarterly peak. The quarter…
- 10-K · July 22, 2025
- Cal‑Maine reported a clear multi-year inflection in fiscal 2025 driven by higher shell egg prices and margin recovery: net sales rose to $4,261,885,000 and net income attributable to Cal‑Maine was $1,220,048,000…
- 10-Q · April 8, 2025
- Cal‑Maine reported a very strong quarter: net sales of $1,417,685,000 and diluted EPS of $10.38 for the thirteen weeks ended March 1, 2025, driven by margin expansion and higher volumes and resulting in large operating…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CALM makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever